Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.11
+0.02 (0.01%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $10.07 billion as of August 3, 2026. Its market cap has increased by 356.96% in one year.
Market Cap
10.07B
Enterprise Value
8.82B
1-Year Change
356.96%
Ranking
Category
Stock Price
$134.11
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $10.07B, an increase of 1,144.78%. That is a compound annual growth rate of 128.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 10.07B | 97.66% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 11.60B |
| Bio-Techne | 11.23B |
| Axsome Therapeutics | 11.22B |
| Madrigal Pharmaceuticals | 10.80B |
| ABIVAX Société Anonyme | 10.54B |
| Cytokinetics | 10.47B |
| Summit Therapeutics | 10.39B |
| Krystal Biotech | 10.06B |